foxo4-dri senolytic 2023 2024 study Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram Senescence Inducers and Senolytics Pathways and Drugs Targeting Cellular Senescence[v1]
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



